Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Integra Lifesciences Holdings (IART) Cost of Revenue (2016 - 2026)

Integra Lifesciences Holdings' Cost of Revenue history spans 17 years, with the latest figure at $214.1 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 10.58% to $214.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $803.6 million, a 10.32% increase, with the full-year FY2025 number at $803.6 million, up 10.32% from a year prior.
  • Cost of Revenue hit $214.1 million in Q4 2025 for Integra Lifesciences Holdings, up from $195.1 million in the prior quarter.
  • Over the last five years, Cost of Revenue for IART hit a ceiling of $214.1 million in Q4 2025 and a floor of $142.6 million in Q1 2022.
  • Historically, Cost of Revenue has averaged $168.7 million across 5 years, with a median of $163.1 million in 2023.
  • Biggest five-year swings in Cost of Revenue: surged 43.41% in 2021 and later decreased 5.32% in 2022.
  • Tracing IART's Cost of Revenue over 5 years: stood at $156.2 million in 2021, then fell by 5.32% to $147.9 million in 2022, then increased by 15.28% to $170.5 million in 2023, then rose by 13.5% to $193.6 million in 2024, then grew by 10.58% to $214.1 million in 2025.
  • Business Quant data shows Cost of Revenue for IART at $214.1 million in Q4 2025, $195.1 million in Q3 2025, and $206.3 million in Q2 2025.